Abstract: The invention relates to an oligonucleotide derivative which comprises at least one nucleoside building block of the formula (I)
The invention furthermore relates to nucleoside building blocks, intermediates and processes for preparing the oligonucleotide derivatives and the nucleoside building blocks. The invention also relates to pharmaceutical compositions and to uses of the oligonucleotide derivatives and the nucleoside building blocks.
Type:
Grant
Filed:
January 3, 2001
Date of Patent:
December 30, 2003
Assignee:
Novartis AG
Inventors:
Bernard Cuenoud, Karl-Heinz Altmann, Pierre Martin, Heinz Ernst Moser